+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Apheresis Equipment: Global Market Analysis, Trends, and Forecasts

  • ID: 338516
  • Report
  • Region: Global
  • 204 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Cerus Corporation (USA)
  • Medica SpA (Italy)
  • Terumo BCT, Inc. (USA)
  • MORE
This report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Types: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis. The Global market is additionally analyzed by the following Procedures: Photopheresis, Plasmapheresis, and Others. Furthermore, the US market is analyzed by the following Therapeutic Areas: Neurology, Hematology & Oncology, Rheumatology, and Others.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 14 companies including many key and niche players such as:

Asahi Kasei Medical Co., Ltd.
B Braun Melsungen AG
Cerus Corporation
Fresenius Kabi AG
Haemonetics Corporation
Kaneka Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cerus Corporation (USA)
  • Medica SpA (Italy)
  • Terumo BCT, Inc. (USA)
  • MORE

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Apheresis Equipment
Donor Apheresis Equipment
Therapeutic Apheresis Equipment
Apheresis Procedures
Photopheresis
Plasmapheresis
LDL-Apheresis (Lipidpheresis)
Plateletpheresis
Erythrocytapheresis
Leukapheresis

2. INDUSTRY OVERVIEW
Apheresis Equipment: An Introductory Prelude
Bright Prospects Ahead for Apheresis Equipment Market
Developed Regions: Primary Revenue Contributors
Table 1: Developed Regions account for nearly 3/4th Share of World Apheresis Equipment Market (2019E & 2024P): Percentage Breakdown of Dollar Sales for Developed and Developing Regions (includes corresponding Graph/Chart)
Fast Paced Growth Projected in Developing Regions
Table 2: Global Apheresis Equipment Market - Geographic Regions Ranked by Value CAGR for 2016-2024: Asia-Pacific, Rest of World, Europe, US, Canada, and Japan (includes corresponding Graph/Chart)
Northbound Trajectory in Healthcare Expenditure Creates Fertile Environment
Table 3: World Healthcare Spending & Growth (in US$ Trillion) and % Real GDP Growth for the Years 2012 Through 2018E (includes corresponding Graph/Chart)
Table 4: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
Table 5: Per Capita Healthcare Spending (in US$) in Select Countries for the Year 2016 (includes corresponding Graph/Chart)
Sustained Increase in Blood & Plasma Collection Programs Instigates Substantial Opportunities
Table 6: Blood Components and Plasma Consumption (in '000 Units) for US, Europe, Japan and Rest of World (2016, 2019E & 2022P) (includes corresponding Graph/Chart)
Table 7: Red Blood Cells Consumption (in '000 Units) for US, Europe, Japan, and Rest of World (2016, 2019E & 2022P) (includes corresponding Graph/Chart)
Table 8: Total Blood Collections (2016): Percentage Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart)
Blood Supply Shortage & Safety Concerns Promote New Demand
Critical Importance of Plasma-Based Products in Diagnostic & Therapeutic Applications Builds Momentum
Resolving Prevailing Issues & Challenges: Critical for Future Success
Expensive Nature of Apheresis Therapy
Lack of Awareness among Patients
Shortage of Qualified Donors
Less Emphasis on Developing and Promoting High-Tech Equipment

3. KEY MARKET TRENDS & DRIVERS
Plasmapheresis: The Primary Procedure Type
Table 9: Plasmapheresis Accounts for About Half of World Apheresis Equipment Sales: Percentage Breakdown of Dollar Sales for Plasmapheresis and Other Procedures (2019E& 2024P) (includes corresponding Graph/Chart)
Off-Label Indications Widen Adoption of Photopheresis Procedure
Plateletpheresis Extends a Handy Tool for Dealing with Bleeding Disorders in Surgeries
Increase in Number of Platelet Donors Drives Apheresis Procedures
Donor Apheresis: Dominant Equipment Category
Table 10: Percentage (%) Share of Donor Apheresis Equipment in the Worldwide Apheresis Equipment Sales (2019E & 2024P) (includes corresponding Graph/Chart)
Table 11: Global Blood Donations by Region - Breakdown by Whole Blood Donations and Apheresis Donations for 2013 (Historical Data) (includes corresponding Graph/Chart)
Table 12: Global Blood Donations - Apheresis Donation as % of Total Blood Donation by Geographic Region (includes corresponding Graph/Chart)
Therapeutic Apheresis Equipment to Witness Strong Growth
Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
Neurology - The Major Application Area for Apheresis Equipment
Technological Advancements and Novel Indications Augur Well
Innovations in Hybrid Devices Gather Steam
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Challenges for Therapeutic Apheresis in Pediatrics Segment
Automated Blood Processing Systems in Open Heart Surgeries
CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Table 13: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 14: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
Table 15: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
Aging Population: A Strong Growth Driver
Table 16: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Table 17: Life Expectancy at Birth (in Years) in Select Countries for 2016 (includes corresponding Graph/Chart)

4. TECHNOLOGY OVERVIEW
Apheresis - The Definition
Apheresis Vs. Whole Blood Collection
Comparison of Apheresis and Whole Blood Collection
The Process of Apheresis - An Overview
Apheresis Procedure
Duration, Frequency, and Efficiency of Apheresis
Segregation of Blood Components
Centrifugation
Centrifugal Cell Separators
Filtration
Side Effects
Types of Apheresis Procedures
Photopheresis
Functioning of THERAKOS™ - A Typical Photopheresis System
Plasmapheresis
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
The Complex Process of Becoming a Donor
Medical Screening
The Process of Plasma Donation
Sources of Blood Plasma
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
TPE: Abnormal Components Removed from Blood
Plasmapheresis: Potential Uses Discovered in the Early Years
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
LDL-Apheresis (Lipidpheresis)
Cytapheresis
Stem Cell Collection
Types of Apheresis Equipment
Donor Apheresis
Process of Donor Apheresis
Automated Blood Donation Procedures
Safety of the Donor
Blood Components Required by Different Patients
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis is Remedial for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
Emerging Applications of Therapeutic Apheresis
Cost of Select Therapeutic Apheresis Procedures: An Overview

1. Photopheresis in GvHD (Graft-Versus-Host Disease)

2. Lipid Apheresis (LDL Apheresis)

3. Plasmapheresis and Other Procedures
Therapeutic Apheresis: What is the Risk Involved?
Replacement Fluid in Therapeutic Apheresis
Replacement Fluids Used in Therapeutic Apheresis
Various Replacement Fluids in Use
Select Replacement Fluids and their Limitations
Table 18: Fluid Balance in Fluid Replacement
Table 19: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart)
Table 20: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart)
Table 21: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

5. BLOOD COMPONENTS & DERIVATIVES
Blood: The Circulating Tissue of Human Body
Ionic Composition of Blood
Types of Blood
General Facts about Blood
General Uses of Blood
Blood - Global Facts
Components of Blood
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Plasma

6. COMPETITIVE LANDSCAPE
Fresenius Kabi, Haemonetics and Terumo BCT: Dominant Vendors of Apheresis Equipment
Table 22: Leading Players in the Global Apheresis Systems Market (2018E): Percentage Breakdown of Value Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
Table 23: Leading Players in the Global Blood Component Collection Market (2018E): Percentage Breakdown of Value Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers

6.1 Focus on Select Global Players
Asahi Kasei Medical Co., Ltd. (Japan)
B Braun Melsungen AG (Germany)
Cerus Corporation (USA)
Fresenius Kabi AG (Germany)
Haemonetics Corporation (USA)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Mallinckrodt Pharmaceuticals (Ireland)
Medica SpA (Italy)
NIKKISO Europe GmbH (Germany)
Terumo BCT, Inc. (USA)

6.2 Product Launches/Approvals/Study Results
Mallinckrodt Releases Latest Study Results for THERAKOS CELLEX System in Treating aGvHD Pediatric Patients
GE Healthcare Life Sciences Unveils Sefia S-2000 Cell Processing System
American Red Cross Receives FDA Approval for BLA for Interstate Distribution of Platelets
Cerus Receives Health Canada Approval for INTERCEPT Blood System for Platelets
Cerus Files for CE Mark Registration for INTERCEPT RBC System
Haemonetics Wins FDA Clearance for Enhancement of NexSys PCS™ Embedded Software
Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
Terumo BCT Receives CE Mark for Spectra Optia® Apheresis System

6.3 Recent Industry Activity
Mallinckrodt Inks Collaboration Agreement with Transimmune
Fresenius Kabi UK to Expand Operations in Runcorn, Cheshire
Fresenius Kabi Announces Expansion Project at Haina Site in Dominican Republic
Fresenius Kabi Opens New Laboratory & Office Areas at Graz Innovation & Development Center
Haemonetics to Relocate Global Headquarters to Boston from Braintree, Massachusetts
UniCAR-Therapy Teams Up with Terumo BCT
Terumo BCT to Establish I&D Centers in India
Terumo BCT Collaborates with StafaCT
Fresenius Kabi to Build New Ware House at Blonie Site in Poland
Haemonetics Renames Shanghai Subsidiary as Haemonetics ( Shanghai) Management Co., Ltd.

7. GLOBAL MARKET PERSPECTIVE
Table 24: World Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 30: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 31: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 33: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 34: World Historic Review for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 35: World 14-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Photopheresis, Plasmapheresis, and Others Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

8.1 The United States
A. Market Analysis
The United States: Most Important Market for Apheresis Equipment
Table 36: Percentage (%) Share of the US in the Worldwide Apheresis Equipment Sales (2019E & 2024P) (includes corresponding Graph/Chart)
While Donor Apheresis Equipment Remains Largest Segment, Therapeutic Segment Registers Strong Growth
Growing Demand for Plasma-based Therapies Fuels Adoption of Plasmapheresis Devices
Blood & Plasma Donations in the US
Blood Donations
Table 37: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart)
Table 38: Blood Donation in the US (2016): Percentage Breakdown of Number of Blood Donations by Type - Apheresis Donation and Whole Blood Donation (includes corresponding Graph/Chart)
Blood Supply and Demand in the US - A Fact Sheet
Criteria for Platelet Donation
Criteria for Double Red Cell Donation
Plasma Donations
Table 39: Plasma Collection in the US for 2012, 2014 & 2016 (in Million Liters) (includes corresponding Graph/Chart)
Select IQPP-authorized Plasma Collection Centers in the US
Competitive Scenario
Table 40: Leading Players in the US Whole Blood Collection Market (2018E): Percentage Breakdown of Volume Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
Table 41: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2018E): Percentage Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
Table 42: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2018E): Percentage Breakdown of Revenues for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart)
Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on Suppliers
An Overview of Regulatory Environment and Reimbursement Scenario
Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
Medicaid Coverage for Therapeutic Apheresis by Various Conditions
Medicaid Coverage for Therapeutic Plasma Exchange
Table 43: Payment Rates for Apheresis Procedures in 2016 & 2017 (In US$) (includes corresponding Graph/Chart)
B. Market Analytics
Table 44: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45: US Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 46: US 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 47: US Recent Past, Current & Future Analysis for Apheresis Equipment by Therapeutic Area - Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 48: US Historic Review for Apheresis Equipment by Therapeutic Area - Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 49: US 14-Year Perspective for Apheresis Equipment by Therapeutic Area - Percentage Breakdown of Dollar Sales for Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.2 Canada
Market Analysis
Table 50: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 51: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 52: Canadian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.3 Japan
A. Market Analysis
Therapeutic Apheresis Market - An Overview
Growing Demand for Cancer Treatments Drives Plateletpheresis Market
B. Market Analytics
Table 53: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 54: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 55: Japanese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4 Europe
A. Market Analysis
Europe Remains a Primary Market for Apheresis Equipment
Blood Banks Scenario in Europe
Table 56: Leading Players in the European Whole Blood Collection Market (2018E): Percentage Breakdown of Volume Sales for Fresenius Kabi, MacoPharma, Terumo BCT and Others (includes corresponding Graph/Chart)
B. Market Analytics
Table 57: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 58: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 59: European 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 60: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 61: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 62: European 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.1 France
Market Analysis
Table 63: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 64: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 65: French 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.2 Germany
Market Analysis
Table 66: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 67: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 68: German 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.3 Italy
Market Analysis
Table 69: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 70: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 71: Italian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.4 The United Kingdom
Market Analysis
Table 72: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 73: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 74: UK 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.5 Spain
Market Analysis
Table 75: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 76: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 77: Spanish 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.4.6 Rest of Europe
Market Analysis
Table 78: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 79: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 80: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.5 Asia-Pacific
A. Market Analysis
Asia-Pacific Emerges as Fastest Growing Market for Apheresis Equipment
Key Factors Influencing Demand for Imaging and Other Medical Equipment in Asia-Pacific
Soaring Investments on Healthcare Infrastructure
Increased Healthcare Awareness Among Population
Proliferation of Medical Tourism
B. Market Analytics
Table 81: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 82: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 83: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 85: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 86: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.5.1 Australia
Market Analysis
Table 87: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 88: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 89: Australian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.5.2 China
Market Analysis
Table 90: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 91: Chinese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 92: Chinese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.5.3 Rest of Asia-Pacific
Market Analysis
Table 93: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 94: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 95: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8.6 Rest of World
Market Analysis
Table 96: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 97: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 98: Rest of World 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

9. COMPANY PROFILES

Total Companies Profiled: 14 (including Divisions/Subsidiaries - 20)

  • The United States (8)
  • Japan (3)
  • Europe (9)
    • Germany (5)
    • Italy (3)
    • Rest of Europe (1)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • B Braun Melsungen AG (Germany)
  • Cerus Corporation (USA)
  • Fresenius Kabi AG (Germany)
  • Haemonetics Corporation (USA)
  • Kaneka Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Mallinckrodt Pharmaceuticals (Ireland)
  • Medica SpA (Italy)
  • NIKKISO Europe GmbH (Germany)
  • Terumo BCT, Inc. (USA)
Note: Product cover images may vary from those shown
Adroll
adroll